AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Anti-Infectives Week articles from January 2003
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Anti-Infectives Week archives from January 2003
Viacom and Kaiser Family Foundation launch initiative to fight HIV/AIDS.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Viacom, Inc., one of the largest media companies in the world, and the Henry J. Kaiser Family Foundation, a leader in health information and research, have launched KNOW HIV/AIDS, an unprecedented,...
Significant reduction in cold symptoms reported with zincum gluconicum.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- New research confirms the efficacy of zincum gluconicum nasal gel in reducing the severity and duration of common cold symptoms when treatment is started as late as the second day of illness.
The...
Clinical study of new Ramoplanin capsule completed.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Genome Therapeutics (GENE) has completed a clinical study comparing the microbiological and pharmacokinetic activity of 2 formulations, capsule, and sachet (powder for reconstitution), of its novel...
Positive phase II results reported with anidulafungin.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Versico, Inc., (VERS) announced positive results from a phase II clinical trial with the company's lead investigational product, anidulafungin, for the treatment of invasive candidiasis/candidemia, the...
King Pharmaceuticals acquires rights to Intal, Tilade, and Synercid.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- King Pharmaceuticals, Inc., (KG) announced the company's acquisition of the rights to three branded prescription pharmaceutical products from Aventis.
The products include the rights in the United...
Enrollment begins in phase III program for Inactine pathogen reduction system.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- V.I. Technologies (Vitex), Inc., (VITX) announced enrollment of the first patient in the phase III program for the Inactine pathogen reduction system for red blood cells.
This patient was enrolled...
Chiron inks agreement for relationship management of blood screening devices.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Axeda Systems, Inc., (XEDA), a provider of device relationship management (DRM) enterprise software and services, announced that Chiron Corp. has licensed the Axeda DRM System to enable the proactive...
TolerRx completes $35 million series C financing.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- TolerRx, Inc., a biopharmaceutical company specializing in the discovery and development of therapies that induce and maintain immunological tolerance and reprogram the immune system to treat patients...
Advances in new drug discovery program profiled.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- At the JP Morgan H&Q Healthcare Conference held January 6-9, William G. Rice, PhD, CEO of Achillion Pharmaceuticals, reported on the clinical and preclinical progress of Achillion's infectious disease...
I-trax's eImmune used to track first 100 Smallpox vaccinations.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- I-trax, Inc., (IMTX), a population health-management solutions company, announced that eImmune, the company's software solution for tracking immunizations, was used to record the first 100 smallpox...